Stockreport

Crinetics Pharmaceuticals prices $500M equity at $50 per share [Seeking Alpha]

Crinetics Pharmaceuticals, Inc.  (CRNX) 
Last crinetics pharmaceuticals, inc. earnings: 3/9 04:10 pm Check Earnings Report
PDF Gross proceeds are expected to be $500M. Underwriters have a 30-day option to purchase up to an additional 1.5M shares. The offering is expected to close on or abou [Read more]